Kanefendt_2023_Br.J.Clin.Pharmacol__

Reference

Title : Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies - Kanefendt_2023_Br.J.Clin.Pharmacol__
Author(s) : Kanefendt F , Brase C , Jungmann N , Fricke R , Engelen A , Schmitz S
Ref : British Journal of Clinical Pharmacology , : , 2023
Abstract : Kanefendt_2023_Br.J.Clin.Pharmacol__
ESTHER : Kanefendt_2023_Br.J.Clin.Pharmacol__
PubMedSearch : Kanefendt_2023_Br.J.Clin.Pharmacol__
PubMedID: 38048692

Related information

Citations formats

Kanefendt F, Brase C, Jungmann N, Fricke R, Engelen A, Schmitz S (2023)
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies
British Journal of Clinical Pharmacology :

Kanefendt F, Brase C, Jungmann N, Fricke R, Engelen A, Schmitz S (2023)
British Journal of Clinical Pharmacology :